Advaxis, Inc.

Empowering the immune system from within™

Advaxis, Inc. was an American biotechnology company focused on the discovery, development, and commercialization of immunotherapies based on a genetically engineered Listeria monocytogenes (Lm) platform that secretes an antigen/adjuvant fusion protein to stimulate an immune response against cancer.

Partnerships